Molecular Analysis Of Leukemia Patients By Next Generation Sequencing Predicts Targeted Therapy Outcome

Imatinib (Gleevec/Glivec, Novartis Pharma) is an oral drug developed to fight a particular type of blood cancer, termed Chronic Myeloid Leukemia (CML), in which there is an abnormal expansion of white blood cells number.

At the molecular level, CML is caused by the formation of an aberrant chromosome, called the Philadelphia chromosome (Ph), which contains a ‘chimaeric’ gene derived from the fusion of two normal genes: BCR/ABL. This fusion gene tells the cells to divide in an uncontrolled manner, leading to leukemia. Imatinib was designed to block the activity of BCR/ABL inside the cells, in a specific way, like a key in the lock: BCR/ABL needs ATP to function, and imatinib occupies the space where ATP would bind, therefore blocking the enzyme activity.

 

Before imatinib, CML was a deadly disease, with a clinical course that clinicians used to divide into three phases: a long, indolent chronic phase followed by a short transition period (accelerated phase) and a final rapid acute phase termed blast crisis, which invariably led to death, unless the patient could undergo bone marrow transplant. Imatinib revolutionized the treatment and the outcome of CML: patients diagnosed in 2017 can expect a normal lifespan, while taking a pill a day, with very limited side effects.

Unfortunately, not all patients do well, even under imatinib. In some cases, the BCR/ABL gene mutates to a drug-resistant version and the disease reappears. New, more potent drugs have been developed to fight back such resistant leukemia.

In a recent paper, we analyzed a cohort of CML patients by Next Generation Sequencing. We sequenced the DNA from their leukemic cells at diagnosis and compared it with that from normal cells. We found that, in addition to the well-known BCR/ABL fusion gene, these patients had multiple other mutations in their cancer.

In order to make sense of this finding, we tried to prioritize mutations according to a novel score that we developed in the lab, the OncoScore (OS). This tool gives a score to any gene by looking in the medical literature: the more a certain gene is associated with keywords such as ‘cancer’ or ‘leukaemia’ in peer-reviewed papers, the higher its score is. We previously demonstrated that genes with OS>22 can be considered as potential oncogenes.

Interestingly, when we correlated the score of our patients mutations with their clinical response to imatinib therapy, we found that patients having higher scores had a higher probability to fail imatinib treatment, thus suggesting that additional somatic mutations in CML can modify the response to imatinib, although BCR/ABL is still the main driver of the disease. As the OS is a gene score, we compared patients carrying several mutated genes by using three ‘patient-level’ scores: the total OS (tOS), which is the sum of OncoScores of all the identified mutations in a patient; the sum of OS values considering only those genes passing the oncogene threshold (OS22 score); or by 2topOS, which is the sum of scores from the two highest-ranking mutated genes in each patient.

All patient scores yielded the same result: imatinib-resistant patients had significantly higher scores compared to responding patients, after a median of 5 years in therapy. Interestingly, the widely used Sokal score (a scoring method based on clinical parameters) was not able to discriminate the two populations, indicating that molecular profiling can be superior to traditional clinical stratification in these patients.

This study, Somatic mutations identified at diagnosis by exome sequencing can predict response to imatinib in chronic phase chronic myeloid leukemia (CML) patients was recently published in the American Journal of Hematology.

About The Author

Luca Mologni

Luca Mologni currently works at the School of Medicine and Surgery, UniversitĂ  degli Studi di Milano-Bicocca. Luca does research in Medicinal Chemistry, Pharmacology and Cell Biology. Their current project is 'Resistance to ALK inhibitors'.

Speak Your Mind!

READ THIS NEXT

Sustainable Energy Production Over Molybdenum Carbide-Based Nanocomposite

Rational design and synthesis of appropriate, eco-friendly, and cost-effective catalysts with preserved chemical and energy functionalities is a vital research gap in the production of renewable and sustainable energy on an industrial scale. The production scheme for renewable and sustainable energy includes CO/CO2 hydrogenation, water-gas shift (WGS) reactions, hydrocarbon isomerization, and methane reforming, and the commercially […]

Marine Microbe Enables Electrically-Mediated Reduction Of CO2

The combustion of fossil fuels by humans contributes to the elevated concentration of atmospheric carbon dioxide, facilitating climate change. In 2017, the transportation sector released around 1.9 billion tons of carbon dioxide, supplanting electricity generation as the nation’s foremost source of atmospheric emissions, according to the United States Energy Information Administration. This shift was largely […]

How Many Days Are In Summer On Average?

How many days are in summer on average? This depends somewhat on how you define summer, whether you are referring to the astronomical season of summer or the meteorological season. In terms of the meteorological summer season, there are 92 days in summer. The meteorological summer begins on June 1 and ends on August 31. […]

Endogenous Control Of Migratory Fueling In A Songbird

The fascination of bird migration lies in the performance of stunningly well-organized journeys by animals of very small size. Birds need to choose the right direction and timing, deal with a variety of environmental conditions and predators, and manage their energy reserves to overcome long-distance flights. Scientists have since long tried to understand how birds […]

Coral Color: The Science Behind Coral

The color coral gets its unique coloration from the organisms that live within the coral, forming a symbiotic relationship with it. The organisms that give coral their color are called zooxanthellae, and the coral reefs provide the organisms with a safe place to live. To better understand the relationship between coral and zooxanthellae, it would […]

Safe Birth Kits: Promise Unfulfilled? Evidence From A Randomized Trial In Northern Nigeria

Published by Jessica Leight Economics Department, American University, Washington, D.C., United States of America These findings are described in the article entitled Associations between birth kit use and maternal and neonatal health outcomes in rural Jigawa state, Nigeria: A secondary analysis of data from a cluster randomized controlled trial, recently published in the journal PLoS […]

Brain Microstructure By Multi-Modal MRI

Understanding the brain is one of the challenges of the 21st century and the target of a large number of research projects currently funded around the world. The difficulties are mainly in the complexity of this organ, which occurs at multiple levels (from cells to system). The brain is made up of cells, including neurons […]